Skip to content
MedsAcross

Medicine

Milnacipran 50 mg tablet

Milnacipran · Oral
Available on requestPrescription onlyUS FDAGeneric name

Milnacipran 50 mg tablet is a generic prescription medicine for oral use, made by 5 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C…

Key facts

Active ingredient (INN)
Milnacipran
Brand
Sold under the generic name
Strength
50 mg
Dosage form
Tablet
Route
Oral
Packs
10 blister pack, 60 tablets, 500 tablets and 6 more
Manufacturers
Macleods PharmaceuticalsIndiaCamber PharmaceuticalsIndiaGlenmark PharmaceuticalsIndiaAmneal PharmaceuticalsBreckenridge Pharmaceutical
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C (59° to 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
N06AX17 Milnacipran
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
31 January 2014
Identifiers
RxCUI 833135, 833141, 833144 +2DailyMed set ID 52ad5462-ed80-417a-964f-56ef1fdce3f2, e39b4890-99e4-4e48-9f45-978d5ac9f402, b66b1850-0d2a-41d6-b0ad-c676166394c7 +2NDC 33342-371, 51991-036, 68462-765 +2Application ANDA210944, ANDA205071, NDA022256 +2

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack31722-848-32Camber PharmaceuticalsIndia19 March 2026
60 tablet, film coated in 1 bottle31722-848-60Camber PharmaceuticalsIndia19 March 2026
60 tablet, film coated in 1 bottle68462-765-60Glenmark PharmaceuticalsIndia19 March 2026
60 tablet in 1 bottle33342-371-09Macleods PharmaceuticalsIndia15 September 2026
10 blister pack in 1 carton / 10 tablet in 1 blister pack33342-371-12Macleods PharmaceuticalsIndia15 September 2026
500 tablet in 1 bottle33342-371-15Macleods PharmaceuticalsIndia15 September 2026
60 tablet in 1 bottle65162-093-06Amneal Pharmaceuticals31 January 2014
500 tablet in 1 bottle65162-093-50Amneal Pharmaceuticals31 January 2014
60 tablet in 1 bottle51991-036-06Breckenridge Pharmaceutical19 March 2026

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 14 January 2009Drugs@FDA
EU (EMA)RefusedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Milnacipran 50 mg tablet.

Compare 1

Other strengths and forms of Milnacipran

Clinical summary

Milnacipran is a serotonin and norepinephrine reuptake inhibitor indicated for the management of fibromyalgia, among other approved uses. It is available as tablets and kits for oral use. MedsAcross supplies Milnacipran for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Milnacipran

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Milnacipran 50 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.